Cargando…
Inhaled Levosimendan versus Intravenous Levosimendan in Patients with Pulmonary Hypertension Undergoing Mitral Valve Replacement
CONTEXT: Inhaled levosimendan may act as selective pulmonary vasodilator and avoid systemic side effects of intravenous levosimendan, which include decrease in systemic vascular resistance (SVR) and systemic hypotension, but with same beneficial effect on pulmonary artery pressure (PAP) and right ve...
Autores principales: | Kundra, Tanveer Singh, Nagaraja, P S, Bharathi, K S, Kaur, Parminder, Manjunatha, N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078018/ https://www.ncbi.nlm.nih.gov/pubmed/30052230 http://dx.doi.org/10.4103/aca.ACA_19_18 |
Ejemplares similares
-
To Evaluate Dexmedetomidine as an Additive to Propofol for Sedation for Elective Cardioversion in a Cardiac Intensive Care Unit: A Double-blind Randomized Controlled Trial
por: Kundra, Tanveer Singh, et al.
Publicado: (2017) -
Effect of dexmedetomidine on diseased coronary vessel diameter and myocardial protection in percutaneous coronary interventional patients
por: Kundra, Tanveer Singh, et al.
Publicado: (2016) -
Impact of the International Quality Improvement Collaborative on outcomes after congenital heart surgery: A single center experience in a developing economy
por: Balachandran, Rakhi, et al.
Publicado: (2015) -
Elevated postoperative serum procalcitonin is not indicative of bacterial infection in cardiac surgical patients
por: Chakravarthy, Murali, et al.
Publicado: (2015) -
Role of inhaled levosimendan in peripartum cardiomyopathy
por: Kaur, Parminder, et al.
Publicado: (2022)